JOHN L. HIGGINS - Corporate Board Profile

BIO-TECHNE Corp

Filing Date	Source Excerpt
2009-09-22	John L. Higgins 39 Director President and Chief 2009 Executive Officer of Ligand Pharmaceuticals Incorporated, since January 2007. Chief Financial Officer for Connetics Corporation from 1997 to 2007. Director of Ligand Pharmaceuticals Incorporated and BioCryst Pharmaceuticals, Inc.
2010-09-17	He graduated Magna Cum Laude with a bachelor's degree from Colgate University. Mr. Higgins has been President and Chief Executive Officer of Ligand Pharmaceuticals Incorporated since January 2007.
2011-09-16	Mr. Higgins graduated Magna Cum Laude with a bachelors degree from Colgate University. He has been CEO of Ligand Pharmaceuticals and held executive roles in finance and corporate development.
2012-09-14	Mr. Higgins graduated Magna Cum Laude with a bachelors degree from Colgate University. He has been President and CEO of Ligand Pharmaceuticals and held executive positions at Connetics Corporation and BioCryst Pharmaceuticals.
2013-09-20	John L. Higgins has served on the Company’s Board since 2009. He has been President and CEO of Ligand Pharmaceuticals and has a background in finance and executive management. ... The Board believes Mr. Higgins is qualified to serve as a Director of the Company due to his biopharmaceutical business, accounting and finance experience.
2014-09-19	John L. Higgins has served on the Company’s Board since 2009. He graduated Magna Cum Laude with a bachelor’s degree from Colgate University. Mr. Higgins has been President and CEO of Ligand Pharmaceuticals and has executive management experience. ... The Board believes Mr. Higgins is qualified to serve as a Director of the Company due to his combination of biopharmaceutical business, accounting and finance experience.
2015-09-18	He graduated Magna Cum Laude with a bachelor’s degree from Colgate University. Mr. Higgins has been President and Chief Executive Officer of Ligand Pharmaceuticals, Inc. since January 2007 and has been a member of Ligand’s Board of Directors since March 2007. From 1997 until joining Ligand, Mr. Higgins was with Connetics Corporation, a specialty pharmaceutical company, as its Chief Financial Officer, and also served as Executive Vice President, Finance and Administration and Corporate Development at Connetics from January 2002 until its acquisition by Stiefel Laboratories, Inc. in December 2006.
2016-09-13	Mr. Higgins has been President and Chief Executive Officer of Ligand Pharmaceuticals, Inc. and has held executive roles in finance and administration.
2017-09-12	Mr. Higgins has been President and CEO of Ligand Pharmaceuticals and has a bachelor’s degree from Colgate University. No software or programming background is indicated.
2018-09-11	Mr. Higgins has served as a director of numerous public and private companies. He graduated Magna Cum Laude with a bachelor’s degree from Colgate University. Among other attributes, skills and qualifications, the Board believes Mr. Higgins is qualified to serve as a Director of the Company due to his combination of biopharmaceutical business, accounting and finance experience as well as his executive management experience.
2019-09-09	He graduated Magna Cum Laude with a bachelor’s degree from Colgate University. Mr. Higgins offers the Board over 20 years of industry experience through his role as Chief Executive Officer of Ligand Pharmaceuticals and leadership roles in other pharmaceutical companies.
2020-09-15	Mr. Higgins offers the Board over 20 years of industry experience through his role as Chief Executive Officer of Ligand Pharmaceuticals and leadership roles in other pharmaceutical companies.
2021-09-14	Mr. Higgins offers the Board over 20 years of industry experience through his role as Chief Executive Officer of Ligand Pharmaceuticals and leadership roles in other pharmaceutical companies. His role with Ligand has given him vital experience in the application of strategic leadership skills within our industry, as well as extensive public company executive and board experience. Mr. Higgins also brings to the Board deep knowledge in accounting and financial matters.
2022-09-14	Bachelor’s degree in economics, Magna Cum Laude, Colgate University. Mr. Higgins offers the Board over 20 years of industry experience through his role as Chief Executive Officer of Ligand Pharmaceuticals and leadership roles in other pharmaceutical companies.
2023-09-13	Mr. Higgins retired as President and Chief Executive Officer and a member of the Board of Directors of Ligand Pharmaceuticals, Inc. in December 2022, where he had served since 2007. Earlier in his career, Mr. Higgins was a member of the healthcare banking team of Dillon, Read & Co. Inc., an investment banking firm.
2024-09-12	Mr. Higgins offers the Board over 20 years of industry experience through his role as Chief Executive Officer of Ligand Pharmaceuticals and leadership roles in other pharmaceutical companies. His extensive financial background is important for his perspective on M&A and his role as Chair of the Audit Committee.